Results 121 to 130 of about 299,860 (168)

A. Pola, La più antica produzione vascolare falisca a figure rosse: elementi stilistici, iconografia e sintassi decorativa, in Notiziario SAIA, XIII-XIV Aprile 2014-April 2016, Annuario, p. 46

, 2016
Angela Pola
core  

Via Pola

, 2009
TRADUZIONE DEL VOLUME VIA POLA, AVIROVIC, Ljiljana, DRAGAN VELIKIC   +2 more
core  

Bispecific Antibody-Based Combination Therapies for B-Cell Lymphomas: Current Evidence and Future Perspectives. [PDF]

Int J Cancer
Cheng M, Li W, Liu M, Zou L.
europepmc   +1 more source

Comparative efficacy and safety of systemic therapies in transplant-eligible and ineligible relapsed/refractory large B-cell lymphoma: a Bayesian network meta-analysis. [PDF]

Transl Cancer Res
Huang L, Chen K, Wang M, Guo C, Li Y, Yu Q, Liu Z, Li Z.   +7 more
europepmc   +1 more source

First-line Polatuzumab vedotin plus R-CHP in primary mediastinal B-cell lymphoma: A real-world study bridging the gap of the POLARIX trial. [PDF]

Ann Hematol
Yang X, Ren Y, Cheng L, Liu Y, Yao J, Tan H, Liu P.   +6 more
europepmc   +1 more source

A. Pola, Album fotografici ed ispirazione artistica. Le pubblicazioni archeologiche degli anni Venti-Trenta del Novecento e le fonti di ispirazione degli artisti neo-etruschi, in G. Bagnasco Gianni (ed.), Fascino etrusco nel primo Novecento, conversando di arti e storia delle arti, Milano 2016, pp. 51- 109

, 2016
Angela Pola
core  

Piero Manzoni e Albisola

, 2006
Pola, Francesca
core  

Diffuse Large B-Cell Lymphoma Masquerading as Cholangiocarcinoma in a Young Adult. [PDF]

ACG Case Rep J
Gil-Lopez F, Lukens FJ, Paz-Fumagalli R, Moustafa MA, Majeed U, Guo R, Morales MC, Riley G, Mousa OY.   +8 more
europepmc   +1 more source

Current Knowledge and Gaps in Geriatric Rehabilitation among Physical and Rehabilitation Medicine Specialists. [PDF]

Ann Geriatr Med Res
Capodaglio P, Antoniadou E, Oh-Park M, Frontera WR, Han DS, Terzic CM, Ambrose AF, Gimigliano F, Pola MS, Kutsal YG, Strasser DC, Nguyen VQ, Bean JF, Seijas V, Lim JY.   +14 more
europepmc   +1 more source

A bridge, not a destination: clarifying the role of polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma. [PDF]

Korean J Intern Med
Yhim HY.
europepmc   +1 more source